| Annual Financials | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 2,159 | 3,223 | 4,336 | 5,530 | 5,886 |
| Expenses | 2,329 | 3,179 | 4,225 | 5,292 | 5,793 |
| EBITDA | -170 | 45 | 111 | 238 | 93 |
| Operating Profit % | -10 % | -1 % | -1 % | 1 % | -10 % |
| Depreciation | 27 | 32 | 29 | 25 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -197 | 13 | 82 | 214 | 93 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -197 | 13 | 82 | 214 | 93 |
| EPS in ₹ | -1.42 | 0.09 | 0.51 | 1.22 | 0.50 |
Niva Bupa Health Insurance Company
Niva Bupa Health Insurance Company
74.77
-0.94
(-1.24%)
Market Cap
₹13,800.39 Cr
PE Ratio
153.76
Volume
2,54,026.00
Day High - Low
₹76.15 - ₹74.60
52W High-Low
₹109.34 - ₹68.54
Key Fundamentals
Market Cap
13,800.39 Cr
EPS
1.22
PB Ratio
3.73
Book Value
20.61
EBITDA
238.10
Dividend Yield
0.00 %
Industry
Insurance Sector
General Insurance ROE Growth %
-
Debt to Equity
0.42
Analyst Rating and Forecast
- By Refinitiv from9 analysts
Actual
Company News
View All News
Niva Bupa Health Insurance Company allotted 11,11,500 equity shares of face value ₹10 each on November 13, 2025, following exercise of options by eligible employees under ESOP Scheme 2020. The newly allotted shares will rank pari-passu with existing equity shares of the company.
Niva Bupa Health Insurance Company reported gross written premium of INR 3,983 crores for H1 FY26, registering 23% growth on a like-to-like basis. The company's IFRS profit after tax more than doubled from INR 60 crores to INR 132 crores compared to the same period last year. The combined ratio improved by 105 basis points to 103.1%, driven by a 2.3% reduction in expense ratio despite a 1.2% increase in loss ratio. Retail health growth reached 28% while retail loss ratio remained flat at 68.1%. The company launched ReAssure 3.0 product and expanded its preferred provider network to 44 cities. Following GST reduction from 18% to 0% on health insurance, the company reported strong demand in October with over 50% retail growth and 15% increase in ticket size. Management passed on the entire GST benefit to distributors and customers. The solvency ratio stands at 2.85x with investment yield of 7.3% on assets under management of INR 8,482 crores.
Niva Bupa Health Insurance Company Limited announced its Q2 FY26 performance with Profit After Tax (IFRS) more than doubling to ₹62 crore from ₹24 crore in Q2 FY25. Retail Health Gross Written Premium (GWP) grew 24.5% year-over-year. The company reported overall GWP of ₹2,108 crore on a without 1/n basis and ₹1,843 crore on a with 1/n basis for Q2 FY26. For H1 FY26, the company recorded ₹3,983 crore GWP (without 1/n) and ₹3,475 crore (with 1/n). The Combined Insurance Service Ratio (IFRS) improved to 103.1%, an improvement of 141 basis points from Q2 FY25. Claims Settlement Ratio reached 95.2% and Solvency Ratio improved to 2.85x. The company covers 23.14 million lives with a Net Promoter Score of 57. Distribution channels showed Individual Agency contributing 31%, Brokers 27%, Bancassurance 20%, Direct business 10%, and Corporate Agents 11% with the fastest year-over-year growth of 44%.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,980.70 | #1 98,528.05 | 36.22 | 24,000.80 | 16.45 | 2,508 | 18.08 | 46.49 | |
384.75 | 67,500.54 | #1 7.06 | #1 49,924.60 | 7.53 | #1 6,974 | #1 54.85 | 50.87 | |
358.30 | 33,082.23 | 64.39 | 9,695.50 | 12.54 | 425 | 51.51 | 53.66 | |
491.00 | 28,868.34 | 55.79 | 16,113.00 | 14.87 | 646 | -50.67 | 48.62 | |
170.99 | 28,179.15 | 25.18 | 43,634.00 | 0.32 | 972 | -38.96 | 25.91 | |
74.77 | #6 13,800.39 | #6 153.76 | #6 5,529.70 | #1 27.52 | #6 214 | #6 -371.54 | 43.11 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
27.52 %
Net Income Growth
161.00 %
Cash Flow Change
103.55 %
ROE
106.20 %
ROCE
31.84 %
EBITDA Margin (Avg.)
67.70 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,782 | 1,078 | 2,301 | 3,308 |
| Fixed Assets | 49 | 52 | 58 | 66 |
| Current Assets | 287 | 455 | 675 | 1,510 |
| Capital Work in Progress | 1 | 4 | 1 | 9 |
| Investments | 2,401 | 3,366 | 5,458 | 8,175 |
| Other Assets | -669 | -2,344 | -3,216 | -4,943 |
| Total Liabilities | 1,782 | 1,078 | 2,301 | 3,308 |
| Current Liabilities | 1,983 | 2,799 | 3,891 | 6,452 |
| Non Current Liabilities | 250 | 250 | -682 | -469 |
| Total Equity | 1,532 | 828 | 2,983 | 3,776 |
| Reserve & Surplus | 125 | -680 | 1,282 | 1,950 |
| Share Capital | 1,409 | 1,511 | 1,700 | 1,827 |
Cash Flow
| Cash Flow | 2017 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 4 | 164 | -12 | 43 | 41 | 78 |
| Investing Activities | -32 | -374 | -723 | -829 | -1,882 | -2,348 |
| Operating Activities | 8 | 257 | 338 | 593 | 813 | 1,654 |
| Financing Activities | 28 | 281 | 374 | 280 | 1,110 | 771 |
Share Holding
| % Holding | Jun 2024 | Nov 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 62.94 % | 55.98 % | 55.98 % | 55.98 % | 55.43 % | 55.41 % |
| FIIs | 0.00 % | 8.63 % | 8.85 % | 8.90 % | 10.76 % | 10.72 % |
| DIIs | 0.00 % | 9.57 % | 9.83 % | 9.70 % | 15.06 % | 15.31 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 4.71 % | 4.43 % | 4.23 % | 5.44 % | 5.40 % |
| Others | 37.06 % | 21.12 % | 20.92 % | 21.19 % | 13.30 % | 13.17 % |
| No of Share Holders | 86 | 1,60,440 | 1,46,255 | 1,36,017 | 1,54,883 | 1,58,550 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 31 Mar 2022 |  Change Of Name | NA | 31 Mar 2022 | 0.00 | 0.00 |
| 25 Nov 2024 |  Quarterly Result Announcement | NA | 25 Nov 2024 | 73.95 | 73.72 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 76.34 | 81.17 |
| 07 May 2025 | Quarterly Result Announcement | NA | 07 May 2025 | 82.33 | 80.85 |
| 31 Jul 2025 | Quarterly Result Announcement | NA | 31 Jul 2025 | 86.84 | 85.17 |
| 26 Aug 2025 |  Annual General Meeting | NA | 26 Aug 2025 | 85.17 | 83.96 |
| 03 Nov 2025 | Quarterly Result Announcement | NA | 03 Nov 2025 | 74.63 | 75.41 |
Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Nov 14, 2025
Nov 14, 2025Disclosure Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 03, 2025
Nov 03, 2025Statement Of Deviation Or Variation For Quarter Ended September 2025Nov 03, 2025
Nov 03, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On November 03 2025Nov 03, 2025
Nov 03, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2025
Oct 28, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Oct 28, 2025
Oct 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 01, 2025
Oct 01, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Disclosure Under Regulation 30 For Receipt Of Approval From IRDAI For The Appointment Of Mr. Milind Gajanan Barve As The Chairman Of The Board Of DirectorsSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 15, 2025
Sep 15, 2025Announcement under Regulation 30 (LODR)-CessationAug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 27, 2025
Aug 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 27, 2025
Aug 27, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 01, 2025
Aug 01, 2025Grant Of Stock OptionsAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Jul 31, 2025Letter To Shareholders Regarding Notice Of The 17Th Annual General MeetingJul 31, 2025
Jul 31, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 31, 2025
Jul 31, 2025Reg. 34 (1) Annual Report.Jul 31, 2025
Jul 31, 2025Notice Of 17Th AGM Scheduled To Be Held On Tuesday August 26 2025 At 02:30 P.M.(IST) Through VC/OAVMJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 31, 2025
Jul 31, 2025Statement Of Deviation/Variation- Quarter Ended June 30 2025Jul 31, 2025
Jul 31, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On July 31 2025Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2025
Jul 24, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 21, 2025
Jul 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 03, 2025
Jul 03, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 30, 2025
Jun 30, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 30, 2025
Jun 30, 2025Announcement under Regulation 30 (LODR)-Credit RatingJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJun 26, 2025
Jun 26, 2025Mutual Fund Holdings
Nippon India Multi Cap Fund Direct-Growth 
Helios Flexi Cap Fund Direct - Growth 
Tata India Pharma & Healthcare Fund Direct-Growth 
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth 
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth 
HDFC Nifty Smallcap 250 Index Fund Direct-Growth 
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth 
SBI Nifty 500 Index Fund Direct-Growth 
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth 
Kotak Nifty Smallcap 250 Index Fund Direct-Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Axis Nifty 500 Index Fund Direct-Growth 
Bandhan Nifty Total Market Index Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 46.65
ATR(14)
Less Volatile 1.76
STOCH(9,6)
Neutral 30.94
STOCH RSI(14)
Neutral 32.00
MACD(12,26)
Bullish 0.09
ADX(14)
Weak Trend 16.51
UO(9)
Bearish 42.32
ROC(12)
Downtrend And Accelerating -0.38
WillR(14)
Neutral -63.54
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
